Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

For Younger Women, Study Reveals Mammography Saves Lives

By Medimaging International staff writers
Posted on 11 Feb 2014
Print article
Image: Mammography unit. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy (Photo courtesy of bartekwardziak / Fotolia).
Image: Mammography unit. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy (Photo courtesy of bartekwardziak / Fotolia).
New findings have demonstrated that mammography remains beneficial for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.

Researchers from University Hospitals (UH) Case Medical Center (Cleveland, OH, USA) and Case Western Reserve University School of Medicine (Cleveland, OH, USA) have published new findings in the February 2014 issue of American Journal of Roentgenology that mammography is an important detection tool for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.

There have been contradictory guidelines recently related to the benefit of yearly mammograms for women in their 40s. The United States Preventive Services Task Force’s guidelines from 2009 recommend against annual screening mammography for women in that age group while the American Cancer Society, American College of Radiology, and other professional societies recommend annual exams beginning at age 40.

“Our findings clearly underscore the impact of neglecting to screen women with mammography for women in their 40s,” said the study’s first author Donna Plecha, MD, director of breast imaging at UH Case Medical Center Seidman Cancer Center and assistant professor at Case Western Reserve School of Medicine. “Foregoing mammography for women in this age group leads to diagnoses of later stage breast cancers. We continue to support screening mammography in women between the ages of 40 and 49 years.”

In the study, the authors compared two groups of women between 40 and 49 years old: women undergoing screening mammography and women with a symptom needing diagnostic workup. The researchers conducted a retrospective chart review of 230 primary breast cancers and found that patients undergoing screening mammography had substantial differences in relation to treatment recommendations, stage at diagnosis and identification of high-risk lesions than symptomatic women needing diagnostic evaluation. They determined that patients in the screened group were diagnosed at earlier stages with smaller tumors and less apt to require chemotherapy and its associated morbidities. They also revealed that screening allows identification of high-risk lesions, which may encourage chemoprevention and lower ensuing breast cancer risk.

Breast cancer is a major health problem and statistics indicate that one in eight women will develop the disease in her lifetime. The stage at which the cancer is detected influences a woman’s likelihood of survival and yearly mammography after the age of 40 enables physicians to identify the smallest abnormalities. In fact, when breast cancer is detected early and limited to the breast, the five-year survival rate is 97%. “Annual screening mammograms starting at the age of 40 saves lives,” concluded Dr. Plecha. “Breast cancers caught in the initial stages by mammography are more likely to be cured and are less likely to require chemotherapy or as extensive surgery.”

Related Links:

University Hospitals Case Medical Center



Print article
Radcal

Channels

MRI

view channel
Image: The results of MRI scans are expected to inform future clinical guidelines for heart disease (Photo courtesy of the University of Leeds).

MRI Helps Identify High-Risk Heart Disease Patients

A new study concludes that magnetic resonance imaging (MRI) scans are the safest and most effective way to identify patients with suspected coronary heart disease (CHD). Researchers at the University... Read more

Nuclear medicine

view channel
Image: The images demonstrate that Ga-68 DOTATATE PET/CT anterior 3D MIP and axial fused images could visualize metastases and change the surgical plan for resection (Photo courtesy of Ronald C. Walker, MD / Journal of Nuclear Medicine).

Study Shows Safety and Efficacy of Imaging Technique for Neuroendocrine Tumors

The results of a new study have demonstrated the safety and efficacy of Ga-68 DOTATATE PET/CT scans, compared to In-111 pentetreotide scans, the current US imaging standard for the detection Neuroendocrine... Read more

General/Advanced Imaging

view channel
Image: Emory radiologists reduce Phantom Limb Pain (PLP) by applying a new non-invasive cryoablation procedure (Photo courtesy of Kevin Makowski, RBP).

Radiologists Demonstrate Minimally Invasive Procedure that can Freeze Phantom Limb Pain

Researchers have presented the results of a study investing the use of cryoablation to reduce Phantom Limb Pain (PLP) in patients with chronic pain in amputated limbs. The researchers showed that interventional... Read more

Imaging IT

view channel

Latest Release of Enterprise Imaging Platform Demonstrated at ACR 2016

A global enterprise diagnostic imaging and advanced visualization solutions provider has demonstrated the latest release of their Enterprise Imaging Platform that features thin-client, server-side processing, and simple diagnostic mobile access. The manufacturer made the announcement at the annual meeting of the American... Read more

Industry News

view channel

UK Health Service to Spend GBP 21.5 Million Upgrading Radiotherapy Resources

The UK’s National Health Service has agreed to acquire linear accelerators, and software from a human care company in a deal valued at GBP 21.5 million. The order includes linear accelerators (linacs), multileaf collimators, and a system for improving the speed and reducing the radiation dose of radiation therapy treatment.... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.